MINI FUTURE LONG - FRESENIUS Stock

Certificat

DE000PF0AW12

Market Closed - Boerse Frankfurt Warrants 15:50:21 2024-05-07 EDT
0.92 EUR +10.84% Intraday chart for MINI FUTURE LONG - FRESENIUS
Current month+2.38%
1 month+48.28%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-05-07 0.86 +3.61% 0
24-05-06 0.83 -2.35% 0
24-05-03 0.85 -3.41% 0
24-05-02 0.88 +4.76% 0
24-04-30 0.84 +3.70% 0

Real-time Boerse Frankfurt Warrants

Last update May 07, 2024 at 03:50 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PF0AW1
ISINDE000PF0AW12
Date issued 2020-03-17
Strike 19.53
Maturity Unlimited
Parity 10 : 1
Emission price 0.93
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.96
Lowest since issue 0.17

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
28.13 EUR
Average target price
36.28 EUR
Spread / Average Target
+28.98%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW